Corpus ID: 32881122

Stem cell therapy: a look at current research, regulations, and remaining hurdles.

@article{Reisman2014StemCT,
  title={Stem cell therapy: a look at current research, regulations, and remaining hurdles.},
  author={M. Reisman and K. Adams},
  journal={P \& T : a peer-reviewed journal for formulary management},
  year={2014},
  volume={39 12},
  pages={
          846-57
        }
}
  • M. Reisman, K. Adams
  • Published 2014
  • Medicine, Biology
  • P & T : a peer-reviewed journal for formulary management
Stem cell therapies offer great promise for a wide range of diseases and conditions. However, stem cell research-particularly human embryonic stem cell research-has also been a source of ongoing ethical, religious, and political controversy. 
Directing Stem Cell Fate: The Synthetic Natural Product Connection.
TLDR
This review provides a summary of natural products that have shown promise in controlling stem cell fate and which have also been fully synthesized thereby providing chemistry platforms for further development. Expand
Access to stem cell data and registration of pluripotent cell lines: The Human Pluripotent Stem Cell Registry (hPSCreg).
TLDR
A short primer on the history of stem cell-based products is presented, the ethical and regulatory issues introduced in the course of working with hPSC-derived products and their associated data are summarized, and the Human Pluripotent Stem Cell Registry is presented as a valuable resource for all stakeholders in therapies and disease modeling based on hPSCs. Expand
Concise Review: The Potential Use of Intestinal Stem Cells to Treat Patients with Intestinal Failure
TLDR
Development of methods to propagate adult human intestinal stem cells (ISCs) and pluripotent stem cells raises the possibility of using stem cell‐based therapy for patients with monogenic and polygenic forms of intestinal failure and establishes the safety of autologous ISC transplantation. Expand
Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance
TLDR
The current methods and limitations of CBT are discussed, based upon experience with biologics production, and how multi-stage cell processing can be integrated into a single bioreactor, in order to develop streamlined cGMP-compliant cell processing systems. Expand
Stem Cells: A Historical Review about Biological, Religious, and Ethical Issues
TLDR
The purpose of the study is to clarify the bioethical position of the various religions today in comparison with the social ones regarding the research and use of embryonic and adult stem cells and to clarify their biological hypostasis regarding the concepts of “conception” and “fertilization”. Expand
Regenerative Injectable Therapies: Current Evidence
TLDR
This review seeks to explore the evidence and discuss appropriate use of the most common regenerative treatments including platelet-rich plasma, prolotherapy, autologous mesenchymal stem cells, human-derived allograft products, and saline. Expand
Physiologically based microenvironment for in vitro neural differentiation of adipose-derived stem cells
TLDR
A critical review of current knowledge is proposed, underscoring that a real advance toward a stable, safe and controllable adipose stem cells clinical application will derive from a synergic multidisciplinary approach that involves material engineer, basic cell biology, cell and tissue physiology. Expand
Characterizing differences between MSCs and TM cells: Toward autologous stem cell therapies for the glaucomatous trabecular meshwork
TLDR
This work focuses on adipose derived mesenchymal stem cells (MSCs) as a potential autologous cell source for TM regenerative medicine applications and describes characterization techniques at the messenger, protein, and functional levels to distinguish MSCs from TM cells. Expand
NELL-1 Increased the Osteogenic Differentiation and mRNA Expression of Spheroids Composed of Stem Cells
TLDR
It is concluded that NELL-1 can be applied for increased osteogenic differentiation of stem cell spheroids. Expand
Ultrasound Therapy: Experiences and Perspectives for Regenerative Medicine
TLDR
A review of the many applications of ultrasound in clinical medicine, with a focus on its value as an adjunct to cell-based interventions, and discusses the various preclinical and clinical studies that have investigated the potential of ultrasound for regenerative medicine. Expand
...
1
2
...

References

SHOWING 1-10 OF 28 REFERENCES
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
TLDR
An overview of the mechanisms underlying the tumorigenic risk of human PSC–based therapies is presented and current advances in addressing these challenges are discussed. Expand
Assessing the safety of stem cell therapeutics.
TLDR
The safety issues pertaining to novel stem cell-derived treatments are set out, knowledge gaps that require further research are identified, and a roadmap for developing safety assessment criteria is suggested. Expand
Induced Pluripotent Stem Cells as a Disease Modeling and Drug Screening Platform
TLDR
Current efforts to create iPSC-dependent patient-specific disease models are discussed and the use of iPSCs for development and testing of new therapeutic agents and the implications for high-throughput drug screening are reviewed. Expand
Patient-specific Induced Pluripotent Stem Cells as a Platform for Disease Modeling, Drug Discovery and Precision Personalized Medicine
TLDR
The latest progress in the application of patient-specific iPSCs for disease modeling, drug screening and cell replacement therapy are summarized, and their impact on precision personalized medicine is discussed. Expand
Challenging the FDA's authority to regulate autologous adult stem cells for therapeutic use: Celltex therapeutics' partnership with RNL Bio, substantial medical risks, and the implications of United States v. Regenerative Sciences.
This Article examines the convergence of three corporations that have attempted to capitalize on translating emerging research into clinical procedures by manufacturing and facilitating the processExpand
Embryonic Stem Cell Research: A Decade of Debate from Bush to Obama
  • V. Murugan
  • Political Science, Medicine
  • The Yale journal of biology and medicine
  • 2009
TLDR
A ban on federal funding for research on newly created human embryonic stem cell lines was intended as a compromise and specified that research on lines created prior to that date would still be eligible for funding, but in practice only 21 lines proved to be of any use to investigators. Expand
Induced Pluripotent Stem Cells to Model and Treat Neurogenetic Disorders
TLDR
Although iPSCs have been used in animal models with promising results to treat neurogenetic disorders, there are still many issues associated with reprogramming that must be addressed before iPSC technology can be fully exploited with translation to the clinic. Expand
Stem cells reprogrammed using chemicals alone
TLDR
Patient-specific cells could be made without genetic manipulation, and it is shown that these cells can be tailored to specific medical needs without needing to be modified in the lab. Expand
Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis
TLDR
FLSs derived from RA and OA could be cell resources for iPSC reprogramming and shown to be compatible by karyotyping, and have the potential to be applied in clinical settings as source materials for molecular diagnosis and regenerative therapy. Expand
The future of organ transplantation.
TLDR
A strategy involving the sequential generation of pleuripotent stem cells, formation of human organs in an adoptive xenogeneic host, the harvesting of human cells, tissues or organs from that host and implantation into the individual from whom the stem cells were obtained as one potential way to generate histocompatible organs is discussed. Expand
...
1
2
3
...